Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn28resultaten gevonden
Klinische farmacologie

Deprescribing of antihypertensives in the elderly

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Dimokrat Hassan
  • Promoters Patricia van den Bemt Liset van Dijk
  • Co-Promoters Jorie Versmissen Karin Hek
  • Jaar 2019 - 2023

The (positive) effects of antihypertensive drugs in the cardiovascular risk management are undoubted. However, like all drugs, antihypertensive drugs also have negative side-effects. Especially the elderly, are more susceptible for these adverse effects. It's not clear whether the benefits outweight the risks. So is it possible to deprescribe antihypertensive drugs and minimise risks for adverse events, while maintining blood-pressure levels in accordance with guidelines?  

Geneesmiddelregulering

Safety assessment and use of biologicals/ biosimilars in clinical practice

  • Universiteit Universiteit Utrecht
  • Promovendus Rosanne Meijboom
  • Promoters Toine Egberts Bert Leufkens
  • Co-Promoters Thijs Giezen Helga Gardarsdottir
  • Jaar 2018 - 2022

The aim of this project is to provide insight in the use of biologicals, including biosimilars, in clinical practice and add to the safe and effective use of these agents. We also provide guidance on the implementation of biosimilars in clinical practice from the perspective of different stakeholders including prescribers, pharmacists and patients.

Farmaceutisch praktijkonderzoek

Verminderen en stoppen cardiometabole medicatie

  • Universiteit Amsterdam Universitair Medisch Centrum
  • Promovendus Jamila Abou
  • Promoters dr. Jacqueline Hugtenburg
  • Co-Promoters dr. Petra Elders prof. dr. Rob van Marum
  • Jaar 2018 - 2022
Geneesmiddelregulering

Healthcare professionals’ views on clinical relevance of new medicines in primary care

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Marloes Dankers
  • Promoters prof. dr. Liset van Dijk prof. dr. Aukje Mantel-Teeuwisse
  • Co-Promoters dr. Marjorie Nelissen
  • Jaar 2019 - 2023

New medicines are evaluated by registration authorities in order to assess their benefit-risk-balance. However, not every new medicine has to have an added therapeutic value compared to already available medicines. The real clinical relevance of new medicine is therefore sometimes unclear. In this research project, we want to investigate the views of healthcare professionals (HCPs) on clinical relevance of new medicines in primary care. We will discuss healthcare professionals’ views on clinical relevance of new COPD and T2DM medicines and also describe the reasons for prescribing new medicines, which is often not in line with guideline recommendations. Finally, we want to investigate how healthcare professionals assess the clinical relevance of medicines that obtained market access in the last years, and to investigate which pharmaceutical gaps (in other words: which diseases cannot be properly treated and would demand new therapies) HCPs identify in their daily practice. 

Klinische farmacologie

Retroperitoneal fibrosis

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Hardjit Kharagjitsing
  • Promoters Prof Dr Teun van Gelder
  • Jaar 2020-2023
Klinische farmacologie

Personalised drug repositioning using gene expression

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Michel Koudijs
  • Promoters Prof Dr Henk-Jan Guchelaar
  • Co-Promoters Dr Stefan Boehringer
  • Jaar 2017-2022

Drug repositioning is the application of existing drugs to new indications. We want to find out if it is possible to find new potentially effective drugs against individual tumors based on their unique gene expression patterns.

Klinische farmacologie

Bariatrische chirurgie en HIV

  • Universiteit Radboud UMC Nijmegen
  • Promovendus Leena Zino
  • Promoters David Burger
  • Co-Promoters Angela Colbers Olivier Richel
  • Jaar 2020 - 2023
Pagina 3 van 4